Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Total 13F shares
-
68,620,081
-
Share change
-
+803,727
-
Total reported value
-
$19,377,529,524
-
Put/Call ratio
-
121%
-
Price per share
-
$283.31
-
Number of holders
-
574
-
Value change
-
+$199,394,101
-
Number of buys
-
285
-
Number of sells
-
251
Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2020
As of 31 Dec 2020,
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) was held by
574 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,620,081 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, STATE STREET CORP, Invesco Ltd., Neuberger Berman Group LLC, WCM INVESTMENT MANAGEMENT, LLC, BAMCO INC /NY/, and Artisan Partners Limited Partnership.
This page lists
581
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.